Novonesis completes MicroBioGen acquisition
Novonesis closed its acquisition of Australian yeast biotechnology firm MicroBioGen, building on a 23% stake held since 2013; all regulatory approvals were obtained.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.